New Jersey’s attorney general filed a lawsuit Thursday against drugmaker Insys Therapeutics Inc., claiming it fraudulently marketed a powerful painkiller for widespread use that was intended to treat serious cancer pain.
NYS Entity Status
NYS Filing Date
NOVEMBER 12, 2013
NYS DOS ID#
NYS Entity Type
FOREIGN BUSINESS CORPORATION
2013 - HELSINN THERAPEUTICS (U.S.), INC.
Around the Web
- New Jersey Sues Insys Over Opioid Painkiller
Thursday Oct 5, 2017
- “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
By Ben Fidler - Wednesday Jun 7, 2017
Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]
- United Therapeutics in Settlement Talks With Justice Department
Thursday Jul 27, 2017
United Therapeutics has set aside $210 million for a possible settlement of a U.S. Justice Department investigation of whether the company’s contributions to patient-assistance charity groups violate federal laws against kickbacks and false claims.
- Economic Trends: To Understand Rising Inequality, Consider the Janitors at Two Top Companies, Then and Now
By NEIL IRWIN - Sunday Sep 3, 2017
Focusing on core competence and outsourcing the rest has made U.S. companies lean, nimble and productive. It has also left lots of people worse off.
- FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
By Ben Fidler - Tuesday Aug 29, 2017
The heat is on Acorda Therapeutics once again. Months after Acorda lost a key group of patents, the FDA has declined to review, at least for now, an experimental Parkinson’s disease drug that is critical to the company’s future. Acorda (NASDAQ: ACOR) said this morning that the FDA has sent the Ardsley, NY, company a […]